Earth Science Tech Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Earth Science Tech Inc in the second quarter 2026?
Earth Science Tech Inc achieved a return on average equity (ROE) of 52.97 % in its second quarter 2026, which is below Earth Science Tech Inc 's average return on equity, which stands at 510.03%.

ROE fell compared to the first quarter 2026, despite the net income growth of 16.16% from the first quarter 2026.

Within the Major Pharmaceutical Preparations industry 9 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 105 to 109.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) II. Quarter	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter
Y / Y Equity Change	59.07 %	71.77 %	82.82 %	76.9 %	-
Y / Y Net Income Change	-12.11 %	51.19 %	9.84 %	341.05 %	18.48 %
Net Income (TTM) in Millions	4	4	4	4	3
Return On Equity (TTM)	52.97 %	61.07 %	65.16 %	73.66 %	67.86 %
ETST's Total Ranking	# 109	# 105	# 0	#	#
Equity (TTM) in Millions	8	7	7	6	5
Seq. Equity Change	9.64 %	4.59 %	21.33 %	14.33 %	18.39 %
Seq. Net Income Change	16.16 %	-44.43 %	41.48 %	-3.76 %	99.82 %

Back to ETST Management Effectiveness >> ETST's 5 Years Annual ROE >> Compare ETST ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 10
Sector	# 22
Overall	# 109

Return On Equity Statistics
High	Average	Low
5566.71 %	510.03 %	-1387.01 %
(Mar 31 2014)		(Mar 31 2018)

ETST Annual Return On Equity	(Mar 31 2026) 2026	(Mar 31 2025) 2025	(Mar 31 2024) 2024	(Mar 31 2023) 2023	(Mar 31 2022) 2022
Total Equity in Millions	7	4	2	1	-2
Y / Y Equity Change	82.82 %	71.21 %	100.91 %	-	-
Net Income in Millions	4	3	1	0	3
Y / Y Net Income Change	10.67 %	300.63 %	-	-	-
Return On Equity	51.14 %	84.49 %	36.11 %	-32.64 %	-

Back to ETST Management Effectiveness >> ETST's 5 Years Annual ROE >> Compare ETST ROE to its Competitors

Annual Roe Comment

In 2026 ROE fell to 51.14 %, despite net income growth.

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ETST's' Return on Equity at Yahoo Finance
ETST's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ETST's Competitors
Subscribers only: Roe for Earth Science Tech Inc 's Suppliers
Subscribers only: Return On Equity for ETST's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Alector Inc	112.21 %
Medpace Holdings Inc	99.76 %
3m Company	93.07 %
Exelixis Inc	85.83 %
Eli Lilly And Company	83.65 %
Rigel Pharmaceuticals Inc	73.94 %
Idexx Laboratories Inc	71.18 %
Tenet Healthcare Corp	57.13 %
Aurinia Pharmaceuticals Inc	51.92 %
Nurix Therapeutics Inc	49.34 %
Carlisle Companies Incorporated	44.18 %
Bristol myers Squibb Company	43.83 %
Zevra Therapeutics Inc	38.02 %
Dexcom Inc	36.56 %
Rallybio Corporation	36.35 %
Caredx Inc	34.08 %
Chemed Corporation	32.10 %
Illumina Inc	31.45 %
Transmedics Group Inc	28.74 %
Acadia Pharmaceuticals Inc	28.03 %
Pro dex Inc	26.91 %
Sotera Health Company	26.41 %
Pacs Group Inc	25.65 %
Standard Biotools Inc	25.58 %
Resmed Inc	25.50 %
Bioventus Inc	24.60 %
Encompass Health Corporation	24.08 %
Iradimed Corporation	23.90 %
Corcept Therapeutics Inc	22.88 %
Msa Safety Inc	21.79 %

Date modified: 2026-11-10T06:26:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.